152 related articles for article (PubMed ID: 14999932)
1. [Establishment of institutional GMP cell processing is mandatory for the development of novel advanced cell and gene therapy].
Maekawa T
Rinsho Ketsueki; 2004 Jan; 45(1):32-8. PubMed ID: 14999932
[No Abstract] [Full Text] [Related]
2. [Education of laboratory technicians at graduate school contributes to development of advanced medical sciences and therapeutics].
Maekawa T
Rinsho Byori; 2004 May; 52(5):430-4. PubMed ID: 15206130
[TBL] [Abstract][Full Text] [Related]
3. The long journey from stem cells to medical product.
Parson A
Cell; 2006 Apr; 125(1):9-11. PubMed ID: 16615881
[TBL] [Abstract][Full Text] [Related]
4. Laying the regulatory path for advanced therapies.
Nat Rev Drug Discov; 2008 Jun; 7(6):464-5. PubMed ID: 18511922
[No Abstract] [Full Text] [Related]
5. Stem-cell research: after the gold rush.
Aldhous P
Nature; 2005 Apr; 434(7034):694-6. PubMed ID: 15815600
[No Abstract] [Full Text] [Related]
6. Role of the blood service in cellular therapy.
Rebulla P; Giordano R
Biologicals; 2012 May; 40(3):218-21. PubMed ID: 22063066
[TBL] [Abstract][Full Text] [Related]
7. Reagent safety issues surface for cell/tissue therapies.
Louët S
Nat Biotechnol; 2004 Mar; 22(3):253-4. PubMed ID: 14990935
[No Abstract] [Full Text] [Related]
8. Cell standardization: purity and potency.
Wagner BJ
Regen Med; 2012 Nov; 7(6 Suppl):89-92. PubMed ID: 23210818
[TBL] [Abstract][Full Text] [Related]
9. Regulation of somatic-cell therapy and gene therapy by the food and drug administration.
Kessler DA; Siegel JP; Noguchi PD; Zoon KC; Feiden KL; Woodcock J
N Engl J Med; 1993 Oct; 329(16):1169-73. PubMed ID: 8377782
[No Abstract] [Full Text] [Related]
10. Re.:"A Death in the Laboratory".
Hurwitz RL
Mol Ther; 2001 Jul; 4(1):4. PubMed ID: 11472099
[No Abstract] [Full Text] [Related]
11. Investigational new drugs submitted to the Food and Drug Administration that are placed on clinical hold: the experience of the Office of Cellular, Tissue and Gene Therapy.
Wonnacott K; Lavoie D; Fiorentino R; McIntyre M; Huang Y; Hirschfeld S
Cytotherapy; 2008; 10(3):312-6. PubMed ID: 18418776
[TBL] [Abstract][Full Text] [Related]
12. The role and activities of the ISCT Regulatory Affairs Committee.
Kelley L
Cytotherapy; 2003; 5(4):279-83. PubMed ID: 12944232
[TBL] [Abstract][Full Text] [Related]
13. Caution urged in trial of stem cells to treat spinal-cord injury.
Barde Y
Nature; 2009 Mar; 458(7234):29. PubMed ID: 19262651
[No Abstract] [Full Text] [Related]
14. [Impact of regulations on translational research in cell and gene therapy: the American experience].
Rousseau RF; Gee AP
Bull Cancer; 2004 Mar; 91(3):239-47. PubMed ID: 15171048
[TBL] [Abstract][Full Text] [Related]
15. Bursting the analytical bubble.
Czap A
Altern Med Rev; 2004 Dec; 9(4):353-9. PubMed ID: 15675033
[No Abstract] [Full Text] [Related]
16. Will regulation be the death of cell therapy in the United States?
Gastineau DA
Bone Marrow Transplant; 2004 Apr; 33(8):777-80. PubMed ID: 14968138
[TBL] [Abstract][Full Text] [Related]
17. FDA scrutinizes LDTs.
Mertz A
MLO Med Lab Obs; 2010 Sep; 42(9):60. PubMed ID: 20929179
[No Abstract] [Full Text] [Related]
18. Characterization of gene therapy products and the impact of manufacturing changes on product comparability.
Simek SL
Dev Biol (Basel); 2005; 122():139-44. PubMed ID: 16375258
[TBL] [Abstract][Full Text] [Related]
19. [DDS technologies from the viewpoint of regenerative medical therapy].
Jo J
Rinsho Ketsueki; 2008 May; 49(5):302-10. PubMed ID: 18572806
[No Abstract] [Full Text] [Related]
20. Doctors' do-it-yourself lab tests: how reliable?
Cohn JP
FDA Consum; 1987 Feb; 21(1):36-9. PubMed ID: 10317855
[No Abstract] [Full Text] [Related]
[Next] [New Search]
